| Product Code: ETC7664187 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Israel`s unfractionated heparin import shipments in 2024 saw a shift in concentration, with top exporters being Belgium, Switzerland, USA, Italy, and Germany. The Herfindahl-Hirschman Index (HHI) indicated a transition from moderate to high concentration within the market. Despite a low growth rate of -12.32% in 2024, the compound annual growth rate (CAGR) from 2020 to 2024 stood at 1.28%. This data suggests a challenging year for unfractionated heparin imports in Israel, potentially influenced by various market dynamics and global factors impacting trade flows.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Unfractionated Heparin Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Unfractionated Heparin Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Unfractionated Heparin Market - Industry Life Cycle |
3.4 Israel Unfractionated Heparin Market - Porter's Five Forces |
3.5 Israel Unfractionated Heparin Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Israel Unfractionated Heparin Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Israel Unfractionated Heparin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cardiovascular diseases in Israel |
4.2.2 Growing geriatric population in Israel |
4.2.3 Rising awareness about the benefits of unfractionated heparin therapy |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval and manufacturing of unfractionated heparin |
4.3.2 Presence of alternative anticoagulant therapies in the market |
4.3.3 High risk of bleeding associated with unfractionated heparin use |
5 Israel Unfractionated Heparin Market Trends |
6 Israel Unfractionated Heparin Market, By Types |
6.1 Israel Unfractionated Heparin Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Unfractionated Heparin Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Israel Unfractionated Heparin Market Revenues & Volume, By Bovine, 2021- 2031F |
6.1.4 Israel Unfractionated Heparin Market Revenues & Volume, By Porcine, 2021- 2031F |
6.2 Israel Unfractionated Heparin Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Israel Unfractionated Heparin Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.2.3 Israel Unfractionated Heparin Market Revenues & Volume, By Clinics, 2021- 2031F |
6.2.4 Israel Unfractionated Heparin Market Revenues & Volume, By Others, 2021- 2031F |
7 Israel Unfractionated Heparin Market Import-Export Trade Statistics |
7.1 Israel Unfractionated Heparin Market Export to Major Countries |
7.2 Israel Unfractionated Heparin Market Imports from Major Countries |
8 Israel Unfractionated Heparin Market Key Performance Indicators |
8.1 Average length of hospital stay for patients receiving unfractionated heparin therapy |
8.2 Number of unfractionated heparin prescriptions filled per month |
8.3 Rate of adverse events reported due to unfractionated heparin use |
9 Israel Unfractionated Heparin Market - Opportunity Assessment |
9.1 Israel Unfractionated Heparin Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Israel Unfractionated Heparin Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Israel Unfractionated Heparin Market - Competitive Landscape |
10.1 Israel Unfractionated Heparin Market Revenue Share, By Companies, 2024 |
10.2 Israel Unfractionated Heparin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here